2018 Annual Meeting | C215 - Case Studies in Behavioral Neurology: Focus on Frontotemporal Degeneration

Date Thursday 04/26/18

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Daniel Kaufer, MD, FAAN

Topic(s)

Learning Objectives Participants should enhance their expertise in recognizing and managing FTD-related disorders and improve clinical assessment skills in cognitive, behavioral, and motor areas; enhance knowledge regarding appropriate use of diagnostic brain imaging and genetic testing, when indicated; and be able to employ a comprehensive therapeutic strategy based on current empirical approaches and an understanding of potential future therapies.

CME Available 3.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Tracks Advanced Practice Provider

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 PM - 07:00 PM	Speaker	Overview / Cases of FTD-PPA Spectrum Daniel Kaufer, MD, FAAN
07:00 PM - 07:30 PM	Speaker	Overview / Cases of PSP-CBD Spectrum Irene Litvan, MD, FAAN
07:30 PM - 08:00 PM	Speaker	Overview / Cases of bvFTD Spectrum Howard J. Rosen, MD
08:00 PM - 08:15 PM	Break	Break
08:15 PM - 09:00 PM	Speaker	Case Presentations Daniel Kaufer, MD, FAAN, Irene Litvan, MD, FAAN, Howard J. Rosen, MD

Faculty Disclosures
Daniel Kaufer, MD, FAAN	No disclosure on file
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.